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S-palmitoylation Is Required for the
Control of Growth Cone Morphology
of DRG Neurons by CNP-Induced
cGMP Signaling
Alexandre Dumoulin†, Alina Dagane, Gunnar Dittmar† and Fritz G. Rathjen*
Max Delbrück Center for Molecular Medicine, Berlin, Germany
Genetic investigations have demonstrated that a specific form of axonal branching - the
bifurcation of afferents from dorsal root ganglia (DRG), cranial sensory ganglia (CSG) and
mesencephalic trigeminal neurons (MTN) – is regulated by a cGMP-dependent signaling
pathway. This cascade is composed of the ligand C-type natriuretic peptide (CNP), the
receptor guanylyl cyclase Npr2, and the cGMP-dependent protein kinase Iα (cGKIα).
In the absence of any one of these components, axons no longer bifurcate, instead
they turn in either an ascending or a descending direction. To gain further mechanistic
insights into the process of axon bifurcation we applied different cell culture approaches
to decipher downstream activities of cGKI in somatosensory growth cones. We
demonstrate that CNP induces an enlargement of DRG growth cones via cGKI which is
considered as the priming step of axon bifurcation in the spinal cord. This growth cone
remodeling was both blocked by pharmacological inhibitors of S-palmitoylation and
potentiated by blocking de-palmitoylation. cGKI colocalizes with the palmitoylome and
vesicular structures including the endoplasmic reticulum, early endosomes, lysosomes
primarily in the central domain of the growth cone as well as with the Golgi apparatus
at the level of the soma. Interestingly, an acyl-biotin-exchange chemistry-based screen
indicated that 8pCPT-cGMP-induced signaling induces S-palmitoylation of a restricted
pool of proteins in the DRG-derived cell line F11. Overall, our data indicate that CNP-
induced cGMP signaling via cGKI affects growth cone morphology of somatosensory
afferents. Moreover, it also suggests that S-palmitoylation might play a role in this
process.
Keywords: cGMP signaling, S-palmitoylation, natriuretic peptide receptor 2, C-type natriuretic peptide, cGMP-
dependent kinase I, growth cone morphology, axon branching
INTRODUCTION
During embryonic development navigating axons often form branches to build a complex and
well-ordered network. Branch formation allows an individual neuron to establish contacts with
distinct targets and thereby provide a framework for parallel processing of signals. Impairment of
the neuronal network formation often leads to neurological disorders like schizophrenia (Bullmore
and Sporns, 2009; Engle, 2010). Thus, unraveling molecular mechanisms regulating different
axonal branching modes is of critical importance. A number of factors including extracellular
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cues, cytoskeletal components and signaling factors have been
described to regulate axon branch formation (Schmidt and
Rathjen, 2010; Gibson and Ma, 2011; Kalil and Dent, 2014;
Armijo-Weingart and Gallo, 2017). However, the mechanism
that drives branching at specific in vivo locations remains poorly
understood.
The projection of dorsal root ganglion (DRG) afferents into
the developing spinal cord is a very accessible and therefore useful
system to investigate several types of axonal branching including
bifurcation, interstitial and terminal branching (Brown, 1981).
DRG central afferents first bifurcate at the dorsal root entry zone
(DREZ) when entering the spinal cord. Then, after a waiting
period they form collateral branches which sprout out from
the axon shafts and invade the spinal cord in a dorso-ventral
manner (Ozaki and Snider, 1997). Finally, they arborize in their
termination fields in the superficial or deeper layers of the spinal
cord where they form synapses (see also Figure 1A1) (Dumoulin
et al., 2018). All three modes of axonal branching are thought to
be activated by distinct signaling systems.
It was previously demonstrated that a cGMP signaling cascade
regulates bifurcation – a specific form of axon branching – of
DRG afferents at the DREZ of the developing mouse spinal cord
(Schmidt et al., 2002, 2007, 2009; Zhao and Ma, 2009; Zhao et al.,
2009; Ter-Avetisyan et al., 2014). This cGMP signaling cascade
is composed of the ligand C-type natriuretic peptide (CNP) that
activates the natriuretic peptide receptor 2 (Npr2, also known
as NPR-B or GC-B), a guanylyl cyclase receptor which produces
cGMP from GTP. Then, cGMP activates the cGMP-dependent
kinase Iα (cGKIα, also called PKGIα) to phosphorylate so far
unknown targets in sensory neurons. If one of these three
components is missing in mouse mutants, sensory axons are
not able to bifurcate and instead form either turns in rostral
or caudal direction (Dumoulin et al., 2018). More recently, this
signaling pathway was shown to be of equivalent importance
for the bifurcation of afferents of cranial sensory ganglia (CSG)
and of mesencephalic trigeminal neurons (MTN) within the
developing hindbrain (Ter-Avetisyan et al., 2014; Ter-Avetisyan
et al., 2018). Consequences of bifurcation deficits are altered
termination fields of primary afferents from the skin in the spinal
cord, impaired noxious heat perception, reduced nociception
induced by chemical irritants and a reduced maximal biting force.
Responses to mechanical stimulation and motor coordination are
surprisingly normal in Npr2 mutants with bifurcation defects
(Troster et al., 2018; Ter-Avetisyan et al., 2018).
Although cell culture experiments analyzing collateral
branching or growth cone activities suggest that cGMP signaling
regulates microtubule dynamics (Xia et al., 2013; Akiyama
et al., 2016) the mechanism of axon bifurcation mediated by
CNP/Npr2/cGMP/cGKIα is entirely unsolved. A multitude
of actions including regulation of adhesion, modulation of
the cytoskeleton (actin polymerization or organization of
microtubules), trafficking of membrane proteins are possible and
might be triggered downstream of cGKIα upon activation by
CNP via Npr2. In the present study we aimed to better define the
CNP-induced effects on DRG growth cones which are mediated
by cGKIα. We used different cell culture approaches of wild
type or cGKI-deficient DRGs to characterize the impact of the
ligand CNP on growth cones. We show that CNP-mediated
cGMP signaling induces an expansion of DRG growth cones and
promotes neurite extension via cGKI which were both blocked by
broad-spectrum inhibitors of palmitoylation. Pharmacological
blocking of de-palmitoylation potentiated the effect of CNP,
increasing the area of the growth cone. In DRG growth cones
cGKI was found to be in close proximity to the palmitoylome and
vesicular structures including the endoplasmic reticulum (ER).
Accordingly, by an acyl-biotin-exchange chemistry approach
we identified a small group of proteins in the DRG-derived F11
cell line that get palmitoylated upon 8-pCPT-cGMP stimulation.
Overall, our findings demonstrate that S-palmitoylation might
play a crucial role for sensory growth cone activities that are
induced by cGMP signaling.
MATERIALS AND METHODS
Mice
cGKI-deficient mice were genotyped as described elsewhere
(Wegener et al., 2002). Animals were housed on a 12/12 h
light/dark cycle with free access to food and water. The
animal procedures were performed according to the guidelines
from directive 2010/63/EU of the European Parliament on
the protection of animals used for scientific purposes. All
experiments were approved by the local authorities of Berlin
(LaGeSO) (numbers T0313/97, G0370/13, and X9014/15).
Cultures of F11 Cells and Embryonic
DRG Neurons, Growth Cone Analysis
F11 cells were maintained in DMEM/F-12 medium
supplemented with GlutaMAXTM (Gibco, #31331028), 10% (v/v)
FCS (Gibco, #16010167), 1% (v/v) HAT supplement (Invitrogen,
#21060017) and 100 U/µL Penicillin(P)/Streptomycin(S) (Gibco,
#15140122) at 37◦C with 95% air and 5 % CO2. Overnight
starvation was in the same medium without FCS.
Dorsal root ganglia single cells or explants were collected
from E12.5 mouse embryos and from E7 chick embryos. For
cell attachment assays DRGs from E13.5 mouse embryos were
prepared to get larger number of cells. For monolayer or culture
in a collagen matrix, DRGs were dissociated by trypsination for
20–30 min at 37◦C in HBSS (Gibco, #24020091). Cells were
dissociated with a fire polished Pasteur pipette and resuspended
in 1 ml DMEM/P/S or DMEM/FCS/P/S (DMEM, Gibco, #61965).
Dissociated cells were plated at 10,000 or 20,000 cells per well
on laminin1 (10 µg/ml; Gibco, #23017-015) or 0.1 mg/ml poly-
D-lysine (PDL) (Sigma, #A-003-M) coated 6-well Lumox R© dishes
(Sarstedt, #94.6077.331) or 12-well glass slides (Ibidi, #81201) in
DMEM supplemented with B27 (Gibco, #17504044), 10 ng/ml
human β-NGF (Alomone labs, #N-245) and either 500 nM CNP
or vehicle or in cell culture medium as indicated. Cells were
incubated overnight at 37◦C with 95% air and 5% CO2.
For neurite length measurements DRG explants or dissociated
cells were cultivated in a collagen matrix. Two hundred microliter
of a collagen mixture constituted of 1 mg/ml collagen (Collagen
I, Rat Tail; Corning, #354236), 1x DMEM (from 10x DMEM,
Sigma, #D2554), 0.5x F12 medium (from 1x F12 medium, Gibco,
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FIGURE 1 | Growth cone splitting of somatosensory afferents at the dorsal root entry zone. (A1) Schematic illustrating the three major branching modes of
somatosensory afferents in the spinal cord: bifurcation, collateral formation and terminal branching and (A2) the two possible options to build a T-shaped branch.
(B) Schematic illustrating the sites at which individual sensory axons were analyzed at the DREZ of the mouse spinal cord. DRG afferents were labeled by the
fluorescent lipophilic axon tracer DiI in the DRG and visualized at the DREZ. (C1,C2) Splitting growth cones in the bifurcation zone (growth cones within the DREZ
that have not bifurcated yet) of the E12.5 mouse spinal cord. (D) A symmetric T-shaped DRG afferent with two growth cones (arrowheads) in the post-bifurcation
zone from an E12.5 mouse embryo. The arrow depicts the bifurcation. (E1) Sensory growth cones (arrowheads) in the bifurcation zone of E12.5 mouse embryos.
(E2) Sensory growth cones (arrowheads) in the post-bifurcation zone (growth cones that have already bifurcated and which are at least 100 µm away from the
bifurcation point) of E12.5 mouse embryos. (F) Quantifications of growth cone areas in the bifurcation zone (n = 22, of these 3 were in the process of splitting
whereas others were enlarged but not in a splitting conformation) and in the post-bifurcation zone (n = 34) from 3 littermate wild type E12.5 embryos. p < 0.0001
(unpaired two-tailed t-test), error bars represent SEM. Scale bar in all images, 20 µm. A.U., arbitrary unit; DREZ, dorsal root entry zone; DRG, dorsal root ganglion;
GC, growth cone; SC, spinal cord.
#31331028) and 0.8% NaHCO3 [from a 7.5% (w/v) stock solution
in ddH2O, Sigma, #S5761] were added to a well (µ-Slide 8 well,
IBIDI, #80826). Then, using forceps one DRG explant was placed
into the center of each well. For single cell cultures, 40,000 cells
were mixed with the aforementioned 200-µl collagen mixture
and added to a well. Collagen gels were allowed to polymerize
at 37◦C with 95% air and 5% CO2 for 45–60 min followed
by adding 200 µl of β-NGF/B27-containing culture medium as
described above in the previous paragraph. Measurements of the
neurite length of DRG monolayer cells or F11 cells was done
with the help of the Simple Neurite Tracer plugin in ImageJ
software (NIH Image, National Institutes of Health, Bethesda,
MD, United States) (Longair et al., 2011). DRG cells attached to
laminin1 or PDL were counted after fixation and staining with
anti-NeuN, anti-L1CAM and DAPI from microscopic images
using ZEN2011 software (Zeiss).
For the measurement of the growth cone area explants
were cultivated overnight on PDL/laminin1 in DMEM/B27
supplemented with 10 ng/ml human NGF or as indicated and
then incubated without or with 500 nM CNP (Sigma, #N8768)
for 1 h. The incubation period of 1 h was deduced from
imaging studies on branching Zebrafish axons (Ponomareva
et al., 2014). Explants were gently fixed with PFA (Merck,
#1040051000)/sucrose (Merck, #573113) in PBS (Wang and
Marquardt, 2012) and stained for α-tubulin and phalloidin (F-
actin) after permeabilization in 0.1% Triton X-100 (Merck,
#1122981001) in PBS. Confocal images were taken with a
100x oil objective and the tracing tool in ZEN software blue
edition (Zeiss) was used to trace the growth cone area. The
beginning of the growth cone was defined by a broadening of
the axon shaft from which on area measurements were started.
As the general growth cone area varied from one independent
experiment to another, growth cone areas were normalized by
the average growth cone area of the control for each independent
experiment. In experiments in which S-palmitoylation was
modulated pharmacological reagents (2BP, Cerulenin, both from
Sigma, #21604 and #C2389 or palmostatin B, Millipore, #178501)
were simultaneously applied together with CNP.
The number of filopodia per growth cone was assessed using
Zen software blue edition (Zeiss) and filopodia length using the
Simple Neurite Tracer plugin in ImageJ software as described
above for monolayer cells (Longair et al., 2011). Note that
values were normalized to the average value of control for each
independent experiment. Statistical analyses were performed
with the Microsoft Excel 2010 software (Microsoft). P-values were
calculated using paired and unpaired two-tailed Student’s t-tests.
Triple compartment neuron device (TCND500, Xona
microfluidics) was used for compartmentalized culture
experiments. Devices were attached to PDL pre-coated Lumox R©
dishes (Sarstedt, #94.6077.331) and laminin1 coating was
performed afterward as described by the supplier. A minimum
of 90,000 E12.5 dissociated DRG neurons were given in
the central channel (soma compartment) and neurons were
incubated for 4–5 days at 37◦C with 95% air and 5% CO2 in
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DMEM supplemented with B27 and 10 ng/ml human β-NGF
(Alomone Labs, #N-245) until DRG axons consistently invaded
both external channels (axonal compartments). Then, culture
medium was removed from both axonal compartments and the
same medium as above supplemented with 500 nM CNP or
vehicle was given separately in each compartment and cells were
incubated 1 h at 37◦C with 95% air and 5% CO2 before fixation
with PFA, 15 min at 37◦C.
Immunocytochemistry and Dil Axon
Tracing
F11 or DRG cells were gently fixed 15 min at 37◦C with pre-
warmed 4% paraformaldehyde (PFA) in PBS and washed 3
times 5 min in PBS at room temperature. They were then
incubated 4 min in PBS, 0.1% Triton X-100 at room temperature,
washed 3 times (5 min each) with PBS and blocked 10 min in
blocking buffer consisting of PBS, 1% heat-inactivated goat serum
(Gibco, #16210064) or 1% BSA (Biomol, #01400.100). Cells were
incubated with primary antibody in blocking buffer for 1 h at
room temperature followed by washing and incubation with the
secondary antibody at room temperature. For explant cultures
staining with primary antibodies was performed overnight at 4◦C
and secondary antibodies 2 h at room temperature. Antibodies
and their dilution are listed in Supplementary Table S1.
Analysis of colocalization was done by the Mander’s approach
(Mander’s colocalization coefficient, MCC) (Dunn et al., 2011)
to investigate the percentage of cGKI-positive pixels colocalizing
to specific intracellular membrane marker (tM1) or vice versa
(tM2). Threshold calculation using the Costes regression (Costes
et al., 2004) was assessed by selecting a region of interest (ROI,
growth cone or whole cell) and with the help of the coloc 2 plugin
from the image processing package Fiji of the Image J software.
All images were captured with a Carl Zeiss LSM 710 NLO
Laser Scanning Microscope equipped with ZEN 2010 software at
a resolution of 1024× 1024 pixels using the following objectives:
a Plan-Neofluar 10x/0.30 NA objective, a Plan-Achromat
40x/1.40 NA oil objective or a Plan-Achromat 100x/1.40 oil DIC
M27 objective (all from Carl Zeiss MicroImaging, GmbH). For
the colocalization studies the pinhole was set at 115 µm. Confocal
z-stacks (2.2 µm in depth) were recorded with a z-interval of
367 nm and assembled using Zeiss ZEN Blue edition software. All
quantifications were performed in ImageJ. Images were imported
into Corel Draw X3 (Corel) for uniform adjustment of contrast
and brightness.
DiI axon tracing was performed as described previously for
DRGs attached to the spinal cord dissected from E12.5 C57BL/6
embryos (Schmidt and Rathjen, 2011).
Immunohistochemistry
Immunohistochemistry on PFA-fixed 15-µm-thick cryostat
E12.5 spinal cord transverse sections was performed as previously
described (Schmidt et al., 2002). Sections were blocked 1h
at room temperature in a blocking buffer consisting of 1%
inactivated goat serum, 0.1% Triton-X100 in PBS and stained
overnight with the primary antibody at 4◦C in the same buffer.
Incubation with the secondary antibody was performed at room
temperature in blocking buffer for 2 h. A list of antibodies used in
this study and their dilutions is given in Supplementary Table S1.
Note that whole embryos were fixed for 4 h at 4◦C with 4% PFA
in PBS and cryopreserved overnight in 30% sucrose in PBS at
4◦C before embedding in O.C.T. compound (Tissue-Tek, Sakura,
#SA62550).
Bioorthogonal Labeling and Click
Chemistry
Visualization of the palmitoylome in growth cones or F11 cells
using bioorthogonal labeling and click chemistry was adapted
from protocols as detailed elsewhere (Gao and Hannoush,
2014). Briefly, embryonic DRG or F11 cells were grown
on PDL/laminin1 coated plates overnight and then further
cultivated in culture medium supplemented with 100 µM
15-azidopentadecanoic acid (palmitic acid azide, Invitrogen,
#C10265) or vehicle overnight. On the next day, cells were
washed 3 times with pre-warmed PBS and then fixed 15 min at
37◦C with pre-warmed 4% PFA in PBS. They were then washed 3
times 5 min in PBS at room temperature.
For click chemistry cells were permeabilized 4 min in PBS
containing 0.1% Triton X-100 at room temperature and washed
6 times (5 min each) with PBS to remove the detergent.
In each well, 100 µl of a solution containing 0.1 mM
Biotin-PEG4-alkyne (Sigma, #764213), 1 mM TCEP [Tris(2-
carboxyethyl)phosphine; Sigma, #C4706] and 1 mM CuSO4
(Sigma, #C1297) in PBS were added and cells were incubated
in the dark at room temperature for 1 h (see scheme of the
click reaction in Supplementary Figure S5). Cells were then
washed 6 times with PBS. Palmitoylated proteins were visualized
by streptavidin-Cy5. The optimal concentration of palmitic acid
azide was established in pre-experiments using F11 cells (see
Supplementary Figures S5B1–B3).
Acyl-Biotin Exchange Chemistry and
Biotinylated Proteins Pull-Down
To identify palmitoylated proteins F11 cells were stimulated
with 1 mM of 8-pCPT-cGMP (Biolog, #C 009-10) for 10 min
followed by subcellular fractionation. F11 cells were prepared by
homogenization in 0.34 M sucrose supplemented with protease
blockers [aprotinin (20 U/µl, Carl Roth, #A162), leupeptin
(5 mM, Sigma, #L2884), pepstatin A (5 mM, Sigma, #P5318),
PMSF (1 mM, Sigma, #P7626)]. Nuclei were pelleted at 200 × g
for 10 min and the resulting supernatant was centrifuged at
100,000 × g for 10 min to obtain a crude membrane pellet
and the cytoplasmic fraction in the supernatant. The membrane
fraction was solubilized in 1% CHAPS (Merck, #1116620010)
in PBS supplemented with protease blockers. Un-solubilized
material was removed by centrifugation at 100,000 × g for
10 min. Palmitoylated proteins were then labeled by the acyl-
biotin exchange (ABE) chemistry protocol as described by
Wan et al. (2007). Free thiols were blocked by NEM (Thermo
Scientific, #23030). Then thioester bonds between cysteines and
palmitate were specifically cleaved by hydroxylamine treatment
and finally newly free thiols were labeled by HPDP-biotin
(Thermo Scientific, #21341) (see schematic in Figure 6D).
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Palmitoylated proteins were purified by streptavidin agarose
pulldown (Thermo Scientific, #434341).
Mass Spectrometric Analysis
Proteins were eluted from the beads using SDS-loading buffer.
The eluted proteins were concentrated into one band and excised
from the gel. The gel pieces were digested using an automated
digestion setup (Kanashova et al., 2015). The eluted peptides from
the in-gel digestion were resuspended in ammonium bicarbonate
buffer. The peptide mixtures were separated by reverse-phase
chromatography using an Proxeon nLC2 (Thermo Scientific,
Dreieich, Germany) on in-house-manufactured 20 cm fritless
silica microcolumns with an inner diameter of 75 µm. Columns
were packed with ReproSil-Pur C18-AQ 3 µm resin (Dr Maisch
GmbH). Peptides were separated using an 8 − 60% acetonitrile
gradient (60 min) at a nanoflow rate of 250 nl/min. Eluting
peptides were directly ionized by electrospray ionization and
analyzed on a Q-Exactive plus mass spectrometer (Thermo
Scientific). The mass spectrometer was operated in a data-
dependent acquisition mode with dynamic exclusion enabled
(30 s). MS1 (mass range 300–1700 Th) was acquired at a
resolution of 70,000 with the ten most abundant multiply charged
(z ≥ 2), ions selected with a 2 Th isolation window for HCD
(Higher-energy collisional dissociation) fragmentation with a
normalized collision energy of 30. MS2 scans were acquired at
a resolution of 17,500 and injection time of 60 ms. The MS2
ion count target was set to 2 × 103 and the max injection time
was 300 ms. Only precursors with a charge state of 2–7 were
sampled for MS2. Data were analyzed by MaxQuant software
version 1.5.1.2. The internal Andromeda search engine was used
to search MS2 spectra against a decoy mouse UniProt database
containing forward and reverse sequences. The search included
variable modifications of methionine oxidation and N-terminal
acetylation, deamidation (N and Q) and fixed modification of
carbamidomethyl cysteine. The minimal peptide length was set
to seven amino acids, and a maximum of two missed cleavages
were allowed. The FDR was set to 0.01 for peptide and protein
identifications. Unique and razor peptides with a minimum
ratio count of 1 were considered for quantification. Retention
times were recalibrated based on the built-in non-linear time-
rescaling algorithm. Statistical analysis was performed using the
R software package1. Significant changes between the samples
were determined using a two-sample t-test after imputation of
missing values.
The mass spectrometry proteomics data have been deposited
to the ProteomeXchange Consortium via the PRIDE partner
repository with the dataset identifier PXD010326 (Vizcaino et al.,
2016).
RT-PCR
Reverse transcription was performed on RNA purified from
either E12.3 mouse DRGs or E17 whole mouse embryos
with RNeasy kit (Qiagen) and reverse-transcribed the
same day into cDNA using the SuperScriptTM II Reverse
Transcriptase kit (Thermo Scientific, #18064014). Primers
1http://www.r-project.org
and PCRs for the 3-hit candidates were designed using
Primer3Plus (Bioinformatics group), Edit Sequ (DNASTAR)
and MapDraw (DNASTAR) softwares. The following
primers were used for amplification of specific cDNAs:
Arhgef2 forward (5′-CTTAAAGGCTGGCTTCGTTG-3′),
Arhgef2 reverse (5′-AGTCCAAGGGTAAGGCTGGT-3′),
Atl2 forward (5′-GCTTGATGAAGAGGCTTTGG-3′), Atl2
reverse (5′-GCCAGTCAAGGGTTCATTGT-3′), Atp2c1
forward (5′-TCAGATGTGGCAAAGCAAAG-3′), Atp2c1
reverse (5′-TAACCAGCCAACCAACATGA-3′), Dad1
forward (5′-GCAGTTCGGCTACTGTCTCC-3′), Dad1
reverse (5′-GTGCTGGCAAAGAGGAAGTC-3′), Zdhhc3
forward (5′-CAGTAGATGGCACTGCAGGA-3′), zdhhc3
reverse (5′-TGTCTTGAGGCCTTTTTGCT-3′), Zdhhc13
forward (5′-AGCTGGTTCTAGCCTGGACA-3′), Zdhhc13
reverse (5′-AGCCCACAGGGTGATCATAG-3′), Gfpt1
forward (5′-ATCCCTTGGTGCCAGTGTAG-3′), Gfpt1
reverse (5′-TGCTGACCTGCATTTCTGAC-3′), Map4
forward (5′-ACCGTTTCAAAAGCCACATC-3′), Map4
reverse (5′-CCAGTGGGAGTGGTGTTTCT-3′), Mcoln1
forward (5′-AAACACCCCAGTGTCTCCAG-3′), Mcoln1
reverse (5′-ACCAGCCATTGACAAACTCC-3′), Ndst1
forward (5′-TGCCAGTGTGTTTTCTCTCG-3′), Ndst1
reverse (5′-ATGGCTGTTAGTGGGACAGG-3′), Rps16
forward (5′-TGAAGCCTCCAAGAAGGAGA-3′), Rps16
reverse (5′-ACAAAGGTAAACCCCGATCC-3′), Slc25a13
forward (5′-TGCTCTTAGCCGGTGCTATT-3′), Slc25a13
reverse (5′-GAGCAGCAACTCCTTTCCAC-3′), Tars
forward (5′-CCATGAACTTAGCCCTGGAA-3′), Tars reverse
(5′-GCAAACTGCTCCTTCTCCAC-3′).
RESULTS
Sensory Axon Bifurcation at the DREZ of
the Spinal Cord Is Carried out by Growth
Cone Splitting
To get further insights into the CNP/Npr2/cGMP/cGKI-
mediated branching we analyzed somatosensory afferents when
entering the spinal cord (Figure 1A1). Two options might be
conceivable to form a T-shaped branch at the DREZ: (1) splitting
of the growth cone or (2) by the budding of a branch from an axon
that had already turned either into an ascending or a descending
longitudinal track (scheme in Figure 1A2). Visualization of
individual sensory axons at the bifurcation zone by labeling of
DRG neurons with the lipophilic axon tracer DiI revealed growth
cones that either seem to equably segregate in two halves or
appear as a symmetric structure like a T (Figures 1C1,C2). In
addition, two branches of somatosensory afferents of equal length
growing in opposite direction in the lateral margin of the cord
were frequently detected (Figure 1D). Therefore, a self-evident
interpretation might be that the two stem axons result from
the equable splitting of the growth cone. These observations
might exclude a process by which the incoming afferent first
turns into the longitudinal track and another branch hereafter
emerges as a collateral branch at the turning point to extend in
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the opposite direction of the longitudinal track. Moreover, in the
bifurcation zone sensory growth cones are twice as large as during
longitudinal extension at the lateral margin of the spinal cord
(Figures 1E1,E2,F and see scheme in Figure 1B).
These changes in the morphology of the growth cone might
involve addition of membrane material and/or reorganization
of cytoskeletal elements. Therefore, to better define the process
of bifurcation we studied DRG growth cones in the presence
of the ligand CNP from wild type and cGKI-deficient mice and
characterized the localization of cGKI in growth cones.
CNP/Npr2-Mediated cGMP Signaling via
cGKI Induces an Expansion of the
Growth Cone Area of Cultured
Embryonic DRG Explants
To unravel the effect of the ligand CNP on Npr2-positive DRG
growth cones and to better understand the function of cGKI
we cultivated embryonic DRG neurons on extracellular matrix
proteins in the presence or absence of CNP for 1 h. [This
incubation period was deduced from imaging experiments of
Zebrafish axons that bifurcate in the periphery (Ponomareva
et al., 2014)]. We observed that CNP increased the growth cone
area of cultured E12.5 mouse DRG explants compared to control
(Figures 2A1–A3, arrowheads) after an incubation period of
1 h. Quantification of the average growth cone area showed
that CNP increased the area up to 86% ± 8% (mean ± SEM)
compared to control (Figure 2A3, p < 0.0001). As the growth
cone population was heterogeneous, we classified growth cones
in three populations according to their area normalized to the
control average area: small (area ≤ 1 [A.U.]), medium (area
between 1 and 1.5) and large (area ≥ 1.5) (Krylova et al.,
2002). This evaluation revealed that CNP stimulation reduces
the number of small growth cones (19% ± 3%, mean ± SEM)
compared to control (59% ± 1%, mean ± SEM, p < 0.05)
whereas it strongly increases the number of large growth cones
(52% ± 1%, mean ± SEM) compared to control (13% ± 1%,
mean ± SEM, p < 0.001) (Figure 2A4). Note, that similar results
were found using E7 chick DRG explants demonstrating that
this effect is conserved among both species (Supplementary
Figures S1A1–B2). The increase in growth cone area was
accompanied with a decline in the length of filopodia on
growth cones, however, their numbers per growth cone remain
unchanged in cultured E7 chick DRG explants (Supplementary
Figures S1C1,C2).
Interestingly, the increase of the growth cone area was also
induced in a three-compartment cell culture system when CNP
was only added to one axon containing chamber while the second
axon compartment served as control (Figures 2B1–B7). This
indicated that the CNP-mediated signal is transduced at the level
of the axon presumably at the growth cone.
To demonstrate that growth cone enlargement induced by
CNP is mediated by cGKI – the downstream effector of
CNP/Npr2 in DRGs – we analyzed DRG explants from cGKI-
deficient mice in the presence or absence of CNP. In DRG
explants from cGKI knockout the average growth cone area
of CNP-treated DRGs was similar to the untreated culture
(Figure 2C1, p > 0.05) and no significant difference was
quantified for the distribution of small, medium or large growth
cones (Figures 2C2,C3, p > 0.05). The majority of growth cones
was small in both conditions (56%± 2% in control and 66%± 4%
in CNP-treated samples, mean ± SEM) whereas a minority was
large (12%± 3% in control and 9%± 1% in CNP-treated growth
cones, mean ± SEM) (Figures 2C2,C3). This indicates that the
CNP-triggered growth cone enlargement requires the cGKI.
In the applied in vitro culture systems we did not detect an
increase of bifurcation of DRG axons in the presence of CNP
as observed in vivo suggesting that additional signals present in
the DREZ might be required to execute bifurcation. However,
assuming that growth cone bifurcation is a complex, multi-
step process, CNP-induced growth cone enlargement might
be considered as the initial priming but compulsory step for
bifurcation. Importantly, the CNP induced enlargement in
growth cone area is accompanied with a significant increase
of tyrosinated tubulin representing the dynamic tubulin pool.
In contrast acetylated tubulin representing stabilized tubulin is
not affected by the presence of CNP for 1 h (Figures 2D1–
D8). Note that all culture experiments with DRG neurons
were done in the presence of NGF indicating that only trkA-
positive axons were studied. However, Npr2 as well as cGKIα
are expressed in all embryonic DRG neurons suggesting that
our observations might also apply to trkA-negative DRG axons
(Schmidt et al., 2007; Ter-Avetisyan et al., 2014; Troster et al.,
2018).
CNP Increased Neurite Length and
Attachment of DRG Neurons on
Extracellular Matrices
In addition to the growth cone enlargement, a long-lasting
effect (16–20 h) of CNP was found on the neurite length as
also described by (Zhao and Ma, 2009) and on the adhesion
of DRG neurons to extracellular matrices. In a 3D collagen
matrix CNP significantly increased the length of neurites from
E7 chicken DRG explants or from dissociated cells, respectively
(Figures 3A1–B3). In addition, an increased neurite length was
also observed for DRG-derived F11 cells (Platika et al., 1985;
Boland and Dingledine, 1990) on laminin1 in the presence of a
cGMP analog (Figures 3C1–C3). Although F11 cells are derived
from DRGs they do not express Npr2 at the protein level (data
not shown) but do express cGKIα. Therefore a cGMP analog was
applied to directly activate the kinase.
Attachment of dissociated E13.5 mouse DRG neurons
identified by the neuronal marker NeuN and by L1CAM on
the extracellular matrix protein laminin1 was increased of about
77% ± 12% (mean ± SEM, p < 0.0001) upon CNP stimulation
after 16–20 h (Figures 3D1–D4). No rise was measured on
the control substrate poly-D-lysine (Figure 3D3, p = 0.14) and
attachment of DRG neurons was dependent on the presence of
cGKI (Figure 3D4).
Overall, our data revealed that CNP induces a growth cone
remodeling of cultured mouse and chicken embryonic DRG
explants or dissociated cells leading to an enlargement within
a period of 1 h with long-lasting effects on neurite length of
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FIGURE 2 | CNP induced a growth cone enlargement via cGKI. (A1–A4) E12.5 mouse DRG explants were grown for 16–20 h on laminin1 followed by treatment with
(500 nM) or without CNP for 1 h. For visualization cultures were stained for α-tubulin (green) and F-actin (red). Arrow heads in A1 and A2 indicate growth cones.
Scale bar, 20 µm. (A3) Quantification of growth cone area in confocal images using ZEN Blue edition software. Control n = 258 growth cones; CNP n = 180 growth
cones from three independent experiments. (A4) Percentages of growth cone areas that were classified into three groups according to their area. Growth cones
were compared to the normalized area value of the control. They were either equal or smaller than the average value 1 (≤1, small growth cone), up to 50% larger
than this value (1 < x < 1.5, medium growth cones) or equal or larger than 50% of this value (≥1.5, large growth cones). (B1–B7) Similar results on growth cone
enlargement of E12.5 mouse DRG dissociated cells were obtained using a three microfluidic chamber culture system in which CNP was applied to one axonal
compartment and the second axonal compartment served as control. Cell somata are in the middle chamber. (B6,B7) Quantification as described for (A3,A4) (green
neurofilament-M). Control chamber n = 87 growth cones; CNP-containing chamber n = 65 growth cones, three independent experiments. Scale bar in (B1) 500 µm;
in (B2–B5) 20 µm. (C1–C3) CNP-induced enlargement of the area of growth cones requires cGKI (E12.5 DRG explants). (C2,C3) Growth cones from E12.5 wild type
(WT) and cGKI-deficient mice treated with CNP or left untreated were classified into three groups as described in A4. cGKI wild type control n = 480 growth cones;
cGKI wild type with CNP n = 319 growth cones; cGKI knockout control n = 250 growth cones; cGKI knockout with CNP n = 349 growth cones. Four independent
experiments. (D1–D8) CNP-induced growth cone enlargement is accompanied with an increase of tyrosinated tubulin. (D1–D6) Control and CNP treated growth
cones from E12.5 mouse DRG explants were stained with anti-tyrosinated tubulin and counterstained with anti-L1CAM. Scale bar, 20 µm. (D7,D8) Quantification of
tyrosinated and acetylated α-tubulin. Tyrosinated tubulin: n = 118 growth cones (control) and 49 growth cones (CNP), three independent experiments; acetylated
tubulin: n = 69 growth cones (control) and 73 growth cones (CNP), three independent experiments. p < 0.0001 (∗∗∗), p < 0.001 (∗∗), p < 0.05 (∗), or p > 0.05 (ns),
unpaired (A3,B6,C1,D7,D8) and paired (A4,B7,C2,C3) two-tailed t-test. Error bars represent SEM. A.U., arbitrary unit; GC, growth cone; KO, cGKI knockout; WT,
wild type.
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FIGURE 3 | CNP increased neurite length and attachment of DRG neurons to extracellular matrices in culture. (A1–A4) Explants of E7 chick DRGs were grown in
collagen matrix in the presence of 500 nM or absence of CNP for 16–20 h and stained with anti-NCAM1 for visualization. Scale bar, 500 µm. (A3) Scheme
illustrating the calculation of the axonal halo from DRG explants (light gray). (A4) Quantification of the axonal halo from explants in the presence or absence of CNP.
Control n = 12 explants; CNP n = 12 explants; three independent experiments; p < 0.0001 (∗∗∗), unpaired two-tailed t-test. (B1–B3) E7 chick DRG single cells
cultured in a collagen matrix in the presence or absence of CNP for 16–20 h. Scale bar, 100 µm. (B3) Quantification of neurite length. Control n = 1671 cells; CNP
n = 1077. (C1–C3) The length of neurites of F11 cells grown on PDL/laminin1 are increased by a cGMP analog (1 mM 8-pCPT-cGMP) treatment overnight. The
average and the maximum lengths increased by 51 ± 4%, (mean ± SEM) and 65 ± 4% on PDL/laminin1, respectively. Three independent experiments n = 923
(control) and 1000 (8-pCPT-cGMP) cells measured p < 0.0001 (∗∗∗), unpaired two-tailed t-test. Scale bar, 100 µm. (D1–D4) Attached E13.5 mouse embryonic DRG
cells on laminin1 or PDL after 16–20 h. (D1,D2) DRG cells were stained with anti NeuN, anti-L1CAM and DAPI and manually counted. (D3) Quantification of attached
cells on laminin1 or PDL treated and untreated with CNP. (D4) Quantification of wild type or cGKI-deficient DRG neurons attaching to laminin1 in the presence or
absence of CNP. Five independent experiments for wild type and 3 for knockout; p < 0.05 (∗). Scale bar in (D2), 100 µm.
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chicken embryonic DRGs and attachment of embryonic mouse
DRG neurons.
cGKI Localizes in a Vesicular-Like
Pattern Primarily in the Central Domain
of Growth Cones of Cultured Embryonic
DRGs
Since CNP-induced growth enlargement depends on the action
of the cGKI we analyzed the localization of cGKI in growth cones
of sensory afferents growing on laminin1 and in cryostat sections
of mouse spinal cords by using a highly specific antibody to cGKI
(Ter-Avetisyan et al., 2014). Cultured DRG neurons of cGKI-
deficient mice are devoid of labeling demonstrating the specificity
of the anti-cGKI antibody (Supplementary Figures S2A1–D3)
At embryonic stages cGKI is localized in a vesicular-like
pattern throughout DRG cells as shown in transverse cryostat
sections of the dorsal funiculus (Figures 4A1–A4), of the
dorsal root (Figures 4B1–B4) and their somata (Figures 4C1–
C4). In cultured DRG neurons cGKI appeared also in a
vesicular-like pattern in the growth cone, the axon shaft and
soma (Figures 4D1,E1 and Supplementary Figure S2A2). For
comparison, the staining phalloidin and of anti-α-tubulin of
the same growth cone are shown which outline the F-actin-
rich peripheral (P)-domain and the microtubule network
of the central (C)-domain of the growth cone, respectively
(Figures 4D2,E2). Intensity profiles of the localization of
α-tubulin and of phalloidin over the complete growth cones
indicated that cGKI is primarily localized within the C-domain
of the growth cone contrasting the pattern of F-actin which
is rich in the P-domain (Figures 4F,G). The pseudo-colored
intensity pattern also clearly showed that vesicular cGKI is more
concentrated in the C-domain of the growth cone (Figure 4H2)
which is opposite to the F-actin (phalloidin) intensity pattern
(Figure 4H1 ). Similar observations were made in DRG growth
cones from the chick (Supplementary Figures S3A1–B2).
To further characterize the subcellular localization of cGKI in
sensory growth cones we performed double staining of anti-cGKI
and different intracellular markers in cultured embryonic mouse
DRG explants (except for GM130 for which dissociated neurons
were analyzed). cGKI appears to colocalize partially with protein
disulfide isomerase (PDI) which is primarily localized in the ER
lumen (Figures 5A1–A4) and present within the C-domain of the
growth cone (Figure 5A2). Visualization in the z-axis (dashed
lines, Figure 5B1) clearly showed colocalization between cGKI
and PDI (Figure 5B2, arrowheads). The colocalization within the
growth cone was quantified using the Mander’s approach (Dunn
et al., 2011). The Mander’ colocalization coefficient (MCC)
calculation indicates a tM1 (cGKI versus PDI) of 0.53 ± 0.03
(mean ± SEM) and a tM2 (PDI versus cGKI) of 0.66 ± 0.03
indicating a colocalization of cGKI and ER structures in growth
cones (Figure 5E). MCC calculations were also performed for
Ras-related protein Rab-5 which is localized at the surface of early
endosomes (Figures 5C1–C4), the lysosomal marker lysosomal-
associated membrane protein 1 (LAMP-1, Figures 5D1–D3)
which is a transmembrane protein localized at the surface of
lysosomes and in the soma for the cis-Golgi marker 130 kDa cis-
Golgi matrix protein which is present at its surface (GM130, not
shown). MCCs calculation indicated a colocalization to different
extents to cGKI, however, a tM2 value higher than 0.40 reveals
a consistent presence of cGKI in structures positive for these
markers (Figure 5E) (Dunn et al., 2011). In addition, when
the entire cell was analyzed similar colocalization values were
measured in the cultured cell line F11 which is derived from
DRG neurons (Supplementary Figure S4). Here, cGKI was also
found in a vesicular-like pattern throughout the cytosol and is
strongly concentrated in the trans-Golgi compartment as well as
in lysosomes, ER and in secretory vesicles positive for γ-adaptin.
Taken together, these results demonstrated that a substantial
portion of cGKI is localized close to intracellular membranes
including the ER, early endosomes and lysosomes primarily
within the C-domain of the DRG growth cones and at the
level of the soma in the Golgi apparatus compartment. The
proximity to those structures suggests that cGKI might regulate
the localization or activity of proteins found in the C-domain to
induce growth cone enlargement and eventually the splitting of
the growth cone in vivo.
cGKI Colocalizes in the DRG Growth
Cone With S-palmitoylated Intracellular
Proteins
The vesicular-like localization of cGKI in the C-domain of
somatosensory growth cones and its proximity to ER and Golgi
structures prompted us to study whether the Npr2-mediated
cGMP signaling cascade might regulate protein trafficking via
S-palmitoylation in sensory growth cones. S-palmitoylation
is a reversible post-translational modification that increases
protein hydrophobicity and facilitates protein interactions with
lipid bilayers. It is involved in the sorting and trafficking of
intracellular proteins and might modify their function. The
majority of palmitoyltransferases are localized in the ER and
Golgi apparatus (Fukata and Fukata, 2010; Chamberlain and
Shipston, 2015).
We asked to which extent palmitoylated proteins are present
in the growth cone of cultured sensory neurons and whether these
co-localize with cGKI. A cell culture approach consisting of the
metabolic incorporation of a palmitate analog into palmitoylated
proteins was applied which were then labeled by a click chemistry
reaction with a biotin moiety (Supplementary Figure S5A)
(Gao and Hannoush, 2014). This strategy allowed us to visualize
the palmitoylome in DRG growth cones and cultured F11
cells by fluorescence microscopy (Figures 6A1–C3). Strikingly,
palmitoylated proteins were omnipresent in the C-domain of
growth cones of cultured mouse embryonic DRG neurons
(Figure 6A1, arrow) and were also found to be enriched in tips
of protrusions of F11 cells (Figure 6B3, arrow, 6C1 for the soma)
as indicated by counterstaining for α-tubulin (Figure 6B2). These
structures partially overlap with cGKI-positive structures within
the C-domain of growth cones suggesting proximity between
palmitoylated proteins and the kinase in growth cones and F11
cells (Figures 6A3,C3). MCC analysis demonstrated a tM1 of
0.84 ± 0.02 (SEM) and a tM2 of 0.73 ± 0.07 (SEM) between
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FIGURE 4 | cGKI localizes in a vesicular-like pattern in sections of embryonic DRG neurons and in the central domain of cultivated DRG growth cones. (A1–A4)
Transversal sections of the developing E12.5 mouse dorsal funiculus, (B1–B4) the dorsal root or (C1 – C4) DRG stained with anti-cGKI, anti-neurofilament-M or the
nuclear stain DAPI. Higher magnifications of the squares indicated in (A1,B1,C4) are shown in (A4,B4,C4) respectively. Scale bar, 10 µm. (D–G) Localization of cGKI
in growth cones of E12.5 DRG explants cultured on laminin1. (D1,D2) cGKI and F-actin (phalloidin). (E1,E2) cGKI and α-tubulin. Scale bar in (D2,E2) 5 µm. (F,G)
Intensity profiles of a growth cone stained with anti-cGKI, F-actin (phalloidin) or α-tubulin summarized throughout the complete growth cone. Note that the intensity
profile shown in (F,G) were taken from the entire growth cone. Along the Y-axis the intensity was summed up and shown along the X-axis (from the left to the right)
using the profile tool in ZEN2011 software (Zeiss). (H1,H2) Pseudo-colored intensity pattern of phalloidin (H1) and cGKI (H2). Scale bar 5 µm. Phall., phalloidin; Lo,
low; Hi, high. A.U., arbitrary unit.
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FIGURE 5 | Colocalization of cGKI with marker proteins of intracellular compartments in DRG growth cones. (A1–A4) Colocalization of cGKI and the ER marker PDI
in growth cones of E12.5 mouse DRG explants. A z-stack image was taken. For comparison the pattern of F-actin together with the localization of PDI is shown in
(A4). (Note: in the upper left corner an axon shaft is growing above the growth cone). (B1,B2) z-stacks taken at the dashed lines showing colocalizing cGKI and PDI
(arrowheads). In (B2) z-stacks are presented as single colors or merged (lower panel). (C) Co-localization between cGKI and Rab5. F-actin is indicated by phalloidin
staining. (D) Co-localization between cGKI and LAMP-1. (E) Quantification of co-localizations using Mander’s colocalization coefficient (MCC). MCC values are given
within the columns. tM1 represents the proportion of cGKI-positive structures colocalizing with structures positive for a specific marker. tM2 represents the
proportion of structures positive for a specific marker colocalizing with cGKI-positive structures. For each condition at least 10 growth cones or cell somata were
analyzed PDI: 26, Rab5: 17, LAMP-1: 12 growth cones and for GM130: 10 somata. Error bars represent SEM. Scale bars, 10 µm.
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FIGURE 6 | cGKI colocalizes with palmitoylated intracellular proteins in growth cones and 8-pCPT-cGMP-induced signaling stimulates S-palmitoylation of a
restricted set of proteins. (A1–A3) Visualization of palmitoylated proteins by metabolic incorporation of a palmitate analog into proteins and by click chemistry in
cultures of dissociated DRGs from E12.5 embryos followed by anti-cGKI staining. Palmitoylated proteins are present primarily in the C-domain (arrow) which overlaps
with cGKI. Scale bar, 5 µm. (B1–B3) Visualization of palmitoylated proteins by the same approach in the center (arrow) of neurite-like protrusions (arrowheads) of F11
cells. For comparison the localization of α-tubulin is shown. The square in (B1) depicts the region enlarged in (B3). Scale bar, 5 µm. (C1–C3) Visualization of
palmitoylated proteins and localization of cGKI in the soma of F11 cells. Scale bar, 5 µm. (D–H) Purification of palmitoylated proteins upon 8-pCPT-cGMP stimulation
by ABE chemistry. (D) Illustration of the labeling procedure of palmitoylated proteins by the ABE chemistry approach (Step a: thiol blockade with NEM, step b:
thioesther bound cleavage with hydroxylamine (HA), step c: biotinylation of free thiols with HPDP-biotin moiety). (E) SDS-PAGE of palmitoylated proteins from F11
cells stimulated or non-stimulated (Ctrl) by 8-pCPT-cGMP (1 mM, 10 min). The post-nuclear fraction containing membrane and cytosolic proteins was used as
control for the labeling procedure by omitting hydroxylamine (-HA). Molecular mass markers are indicated at the left of the panel. mf, crude membrane fraction; cf,
cytosolic fraction; pnf, post-nuclear fraction. (F) Western blotting using anti-GAP43 and anti-Rac1 – two known palmitoylated proteins which were not enriched in
the 8-pCPT-cGMP-stimulated fractions (Gap43 served as a positive control for the crude membrane fraction and rac1 for both cytosolic and membrane fractions).
Note that no signal was detected in the sample without HA treatment revealing the specificity of the purification of S-palmitoylated proteins. (G) S-Palmitoylation of
15 proteins was increased upon cGMP stimulation in F11 cells in three independent experiments. Label-free LC-MS was used for quantification. Data are shown as
log2 of the ratio between cGMP treated and untreated samples from the crude membrane fractions. 1 was given to control when it was equal to zero. Note that no
change of S-palmitoylation for Gap43 upon cGMP stimulation was measured corroborating the Western blotting results in (F). p < 0.05 (∗), p < 0.001 (∗∗).
(H) Classification of proteins that were palmitoylated upon 8-pCPT-cGMP stimulation in 3 and 2 independent experiments (in total 60 proteins).
cGKI and the palmitoylome for F11 cells. Overall, our data might
suggest a role of cGMP signal transduction on palmitoylation.
8-pCPT-cGMP-Induced Signaling
Regulates S-palmitoylation of a Subset
of Proteins in the DRG-Derived Cell Line
F11
In order to investigate by biochemical approaches a possible
link between cGMP signaling and protein S-palmitoylation we
took advantage of the acyl-biotin-exchange (ABE) chemistry to
purify S-palmitoylated proteins from cell lysates. In short, in
this method free thiols are first blocked with N-ethylmaleimide
(NEM), palmitates are then cleaved with hydroxylamine (HA)
and new free thiols are labelled with a biotin moiety (HPDP-
biotin, Figure 6D) (Wan et al., 2007). Since insufficient protein
material was obtained from embryonic DRGs the F11 cell line
was used.
We briefly stimulated (10 min) the cGMP signaling cascade
in F11 cells with a cGMP analog (1 mM of 8-pCPT-cGMP),
fractionated the samples and proceeded to the labeling of
S-palmitoylated proteins using the ABE chemistry and a
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streptavidin-based pull down to purify biotinylated proteins.
Hence, we purified the palmitoylomes from the crude membrane
fraction (mf) as well as the cytosolic fraction (cf) of F11 cells
stimulated or untreated with the cGMP analog as revealed by
silver staining in a SDS-PAGE (Figure 6E). Note that the post-
nuclear fraction (pnf) of unstimulated samples was used as a
control in which the hydroxylamine (HA) treatment was omitted
to identify proteins that were unspecifically biotinylated and/or
pulled down (Figures 6E, -HA). The same samples were also
immunoblotted for the known S-palmitoylated proteins such as
the growth-associated protein 43 (Gap43) (Skene, 1989) or the
Ras-related C3 botulinum toxin substrate 1 (Rac1) (Navarro-
Lerida et al., 2012). No Gap43 or Rac1 signal was detected
in the HA-negative control demonstrating the specificity of
the ABE-based purification toward S-palmitoylated proteins
(Figure 6F). GAP43 was found in the crude membrane fraction
and Rac1 in the cytoplasmic fraction as well. Interestingly,
label-free liquid chromatography–mass spectrometry (LC-MS)
analysis of the membrane fractions revealed that stimulation
by cGMP derivative 8-pCPT-cGMP resulted in an increased
S-palmitoylation of 15 proteins (Figure 6G) which were
consistently identified in 3 independent samples (3-hit protein
candidates) stimulated by the cGMP analog but not in
controls (unstimulated). Several of these proteins have also
been detected in screens to be palmitoylated (see Table 1 for
the corresponding literature). Other palmitoylated proteins like
Gap43 were purified from the crude membrane preparation
in both samples (stimulated and unstimulated) at a similar
level corroborating immunoblotting results shown in Figure 6F
(log2 ratio close to 0). Moreover, a certain number of 2-
hit candidates were found to be enriched in the 8-pCPT-
cGMP-treated membrane fraction suggesting that this list of
15 candidates might be underestimated and together with
2-hit candidates forms a pool of about 60 proteins which
get palmitoylated by 8-pCPT-cGMP-induced signaling and
which are involved in various functions such as metabolism,
transcription, signaling, membrane trafficking or cell adhesion
(Figure 6H and Supplementary Table S2). mRNAs of 3-hit
candidates were also shown to be expressed by RT-PCR in
embryonic DRGs (Supplementary Figure S6).
Taken together, although side effects of 8-pCPT-cGMP
cannot be excluded our biochemical results suggests that 8-
pCPT-cGMP-induced signaling regulates the S-palmitoylation
of a restricted pool of proteins in the DRG-like F11 cell
line.
S-palmitoylation Is Essential for
CNP-Induced Growth Cone Enlargement
and Neurite Extension
Next, we investigated whether S-palmitoylation and CNP-
induced growth cone enlargement are linked in embryonic
DRG neurons. Therefore, we took advantage of the broad
spectrum S-palmitoylation inhibitor 2-bromopalmitate (2-BP)
that blocks palmitoyltransferases (Chamberlain and Shipston,
2015) and applied it to cultured E7 chick DRG explants
on PDL/laminin1. Remarkably, a low-dose of 2BP (20 µM)
abolished the CNP-mediated expansion of the embryonic chick
DRG growth cone without affecting the growth cone morphology
when given alone (Figures 7A1–A4, arrowheads). Whereas
CNP stimulation induced an increase in the average growth
cone area of 67% ± 4% compared to control (mean ± SEM,
p < 0.0001), the presence of 2BP inhibited the enlargement
effect of CNP to control values (Ctrl and 2BP, p > 0.05)
(Figure 7A5). A classification of growth cones into 3 populations
according to area as described above showed that the CNP-
based increase in large growth cones (53% ± 4% compared to
11% ± 1% in control, mean ± SEM, p < 0.05) (Figure 7A6)
was reversed to control values by blocking S-palmitoylation (Ctrl
and 2BP, p > 0.05) (Figure 7A6). The opposite was observed
for the small growth cone population (≤1 A.U.). The presence
of CNP decreased the percentage of small growth cones from
58% ± 1% (mean ± SEM) down to 15% ± 3% (mean ± SEM,
p = 0.006) (Figure 7A6) whereas 2BP completely blocked the
CNP effect by reaching 59% ± 6% (mean ± SEM, p > 0.05)
(Figure 7A6). Note that the medium group of growth cones
remained constant across all experimental conditions (around
30%, p > 0.05) (Figure 7A6). Importantly, 2BP application
alone had no effect on the average growth cone area or on the
growth cone area distribution compared to control (p > 0.05)
(Figure 7A6). Similar results were obtained by applying 8-pCPT-
cGMP (50 µM) instead of CNP indicating that S-palmitoylation
is required downstream of cGKI and not upstream of Npr2
(Figures 7B1–B6).
Cerulenin that inhibits fatty acid and steroid biosynthesis
(Baenke et al., 2013) and thereby interferes with S-palmitoylation
also blocked the effect CNP on growth cone morphology
of cultured E7 chick DRG explants to a similar extent as
2BP (Figures 7C1–C6). The average growth cone area in
cultures treated with CNP and Cerulenin reached control
values and also the classification of growth cones into
three groups correlated with the control allocation. These
results demonstrated that S-palmitoylation promotes CNP-
mediated growth cone remodeling of cultured embryonic DRG
explants.
2BP also reversed the long-lasting effect of CNP on the neurite
length of E7 chick DRG explants or monolayers (Figures 8A1–
B6). Blocking S-palmitoylation by using 2BP at a concentration
of 100 µM significantly impaired the axonal outgrowth of
embryonic chick DRG explants in a collagen gel matrix in
the presence of either 10 or 5 ng/ml NGF cultured overnight
(Figure 8A5). The relative axonal halo length of explants was
significantly reduced to around 20% in both cases (p < 0.05
and p < 0.0001) (Figure 8A5). Similar results were obtained
by applying CNP and 20 µM 2BP to dissociated E7 chick
DRG monolayer cells in a collagen gel without any difference
in the axonal outgrowth compared to control (Figures 8B1–
B6).
As S-palmitoylation blockade prevents the CNP-Npr2-cGKI-
mediated growth cone remodeling we tested whether the opposite
- de-palmitoylation – affects DRG growth cone morphology.
Thus, we challenged growth cones from E7 chick DRG explants
with CNP together with 20 µM of the acyl protein thioesterase
1 blocker palmostatin B (PalmB) (Dekker et al., 2010). Blocking
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TABLE 1 | 3-hit palmitoylated protein candidates which were detected only in the F11 membrane samples stimulated with 8-pCPT-cGMP are listed.
Gene name Protein name Putative cGKI
phosphorylation motif
CSS palm 3.0 (high
threshold)
Literature (MS analyses)
Arhgef2 Rho guanine nucleotide exchange
factor 2
RRRS;RKMT Yes Chesarino et al., 2014
Map4 Microtubule-associated protein 4 KKPT;KKVS;KRTS;
KRPT;KRMT;KRNT
Yes Yang et al., 2009; Wan
et al., 2013; Chesarino
et al., 2014; Thinon et al.,
2016
Fv4 Retrovirus-related Env polyprotein
from Fv-4 locus
KRAT Yes Chesarino et al., 2014
Zdhhc13 Palmitoyltransferase ZDHHC13 No No Li et al., 2012; Chesarino
et al., 2014; Wei et al.,
2014; Thinon et al., 2016;
Shen et al., 2017;
Sobocinska et al., 2018
Dad1 Dolichyl-
diphosphooligosaccharide–protein
glycosyltransferase subunit DAD1
No No Martin and Cravatt, 2009;
Sobocinska et al., 2018
Atl2 Atlastin-2 RRQT Yes Shen et al., 2017
Rps16 40S ribosomal protein S16 RKKT No Martin and Cravatt, 2009 ;
Forrester et al., 2011;
Wilson et al., 2011; Gould
et al., 2015; Serwa et al.,
2015; Hernandez et al.,
2016
Zdhhc3 Palmitoyltransferase ZDHHC3 No Yes Chesarino et al., 2014;
Sobocinska et al., 2018
Ndst1 Bifunctional heparan sulfate
N-deacetylase/N-sulfotransferase 1
KRLS Yes Li et al., 2012
Mcoln1 Mucolipin-1 RRAS;RRGS Yes Vergarajauregui and
Puertollano, 2006; Li et al.,
2012; Collins et al., 2017;
Sobocinska et al., 2018
Gfpt1 Glutamine–fructose-6-phosphate
aminotransferase [isomerizing] 1
KKGS;RRGS Yes Yang et al., 2009; Peng and
Hang, 2015; Serwa et al.,
2015; Thinon et al., 2016
Tars Threonine–tRNA ligase,
cytoplasmic
KKKS;KKET Yes Shen et al., 2017
Atp2c1 Calcium-transporting ATPase type
2C member 1
KRAS Yes Kang et al., 2008; Serwa
et al., 2015; Collins et al.,
2017
Slc25a13 Calcium-binding mitochondrial
carrier protein Aralar2
No No Li et al., 2012; Gould et al.,
2015; Hernandez et al.,
2016; Shen et al., 2017
Putative cGKI phosphorylation motifs were screened as well as putative S-palmitoylated cysteines using the CSS palm 3.0 software set on high threshold (Ren et al.,
2008). Candidates were also screened whether they had already been purified in previous palmitoylated proteins screens using the “SwissPalm: Protein Palmitoylation
database” (Blanc et al., 2015).
de-palmitoylation potentiated the effect of CNP on the growth
cone enlargement compared to CNP alone (Figures 8C1–C6,
arrowheads). The average area of growth cones treated with both
CNP and PalmB was increased of about 97%± 5% (mean± SEM)
compared to control whereas CNP alone increased the area of
about 58% ± 4% (mean ± SEM, p < 0.0001) (Figure 8C5). Note
that PalmB alone significantly increased the average growth cone
area of about 16% ± 4% (Figure 8C5, p < 0.001). Consistently,
PalmB and CNP together induced a decrease in the percentage of
small growth cones down to 5% ± 1% (mean ± SEM) compared
to the 20% ± 2% of CNP alone (mean ± SEM, p < 0.05)
and an increase in the percentage of large growth cone up to
70% ± 3% (mean ± SEM) compared to CNP alone that was
of about 52% ± 2% (mean ± SEM, p < 0.05) (Figure 8C6).
Note that PalmB itself did not induce a significant change in
the percentage of the growth cone population (Figure 8C6,
p > 0.05). These results indicate that blocking de-palmitoylation
potentiates the CNP-mediated growth cone remodeling and are
in line with the experiments in which S-palmitoylation was
blocked.
Taken together, our results suggest that S-palmitoylation
might play a role downstream of cGKI in the CNP-mediated
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FIGURE 7 | S-palmitoylation is required for CNP-mediated growth cone enlargement. (A1–A4) Control versus CNP-treated E7 chick DRG growth cones (explants)
(arrowheads) in presence or absence of 20 µM 2BP and stained for α-tubulin (green) and F-actin (red). (A5) Quantification of the average area of growth cones
treated as in (A1–A4). Number of growth cones measured: 271 (control), 252 (CNP), 494 (2BP) and 482 (2BP CNP) from 3 independent experiments. (A6)
Percentages of growth cones that were classified into three groups according to their area as introduced Figure 2A4. (B1–B4) Control versus 8-pCPT-cGMP
(50 µM) treated E7 chick DRG growth cones (explants) (arrowheads) in presence or absence of 20 µM 2BP and stained for α-tubulin (green) and F-actin (red). (B5)
Quantification of the average area of growth cones treated as in (B1–B4). Number of growth cones measured in three independent experiments: 332 (control), 374
(cGMP), 382 (2BP) and 350 (2BP plus 8-pCPT-cGMP). (B6) Percentages of growth cones that were classified into three groups according to their area. (C1–C6)
Control versus CNP-treated E7 chick DRG growth cones (explants) (arrowheads) in presence or absence of 20 µM Cerulin and stained for α-tubulin (green) and
F-actin (red). (C5) Quantification of the average area of growth cones treated as in (B1–B4). Number of growth cones measured in three independent experiments:
202 (control), 193 (CNP), 215 (Cerulenin), 266 (Cerulenin plus CNP). (C6) Percentages of growth cones that were classified into three groups according to their area.
p < 0.0001 (∗∗∗), p < 0.001 (∗∗), p < 0.05 (∗), or p > 0.05 (ns), unpaired (A5,B5,C5) and paired (A6,B6,C6) two-tailed t-test. Error bars represent SEM. A.U.,
arbitrary unit; Cer., Cerulenin, Ctrl, control. Scale bars: 20 µm.
growth cone remodeling and propose that S-palmitoylation
might be also important for axon bifurcation in vivo.
DISCUSSION
Previous publications have shown that a cGMP signaling cascade
including the ligand CNP, the guanylyl receptor Npr2 and the
serine/threonine kinase cGKI is implicated in the bifurcation
of all somatosensory afferents in the developing spinal cord
or hindbrain (for a review see Dumoulin et al., 2018). CNP
expressed in the dorsal spinal cord (Schmidt et al., 2009) and
in specific rhombomeres of the hindbrain at early embryonic
stages (Ter-Avetisyan et al., 2018) binds to Npr2 on afferents
on somatosensory neurons which in turn generates cGMP
from GTP. Then, cGMP binds to cGKI and thereby induces a
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FIGURE 8 | CNP-induced neurite extension is abolished by 2BP and growth cone enlargement is increased by interfering with acyl protein thioesterase 1
(APT1)-mediated de-palmitoylation. (A1–A4) E7 chick DRG explants were cultured overnight in a collagen matrix in either the presence of 500 nM CNP, 100 µM 2BP
or 500 nM CNP plus 100 µM 2BP. Explants were then fixed and stained for NCAM1. (A5) CNP stimulation increased the axonal outgrowth of about 20% ± 4%
(10 ng/ml NGF, mean ± SEM) and 22% ± 2% (5 ng/ml NGF, mean ± SEM). Blocking S-palmitoylation by 2BP inhibited the CNP-mediated axonal outgrowth
increase. 100 µM 2BP itself inhibited axonal outgrowth compared to control (–22% ± 4% in 10 ng/ml NGF and –20% ± 3% in 5 ng/ml NGF, mean ± SEM). For
measurement of axon outgrowth see also Figure 3A3. Number of explants assessed at 10 ng/ml NGF: 19 (Ctrl), 19 (CNP), 18 (2BP) and 18 (2BP plus CNP).
Number of explants assessed in 5 ng/ml NGF: 13 (Ctrl), 15 (CNP), 16 (2BP) and 16 (2BP plus CNP). Three independent experiments per NGF concentration. Scale
bar, 500 µm. (B1–B4) E7 chick DRG single cells were cultured overnight in a collagen matrix either in the presence of 500 nM CNP, 20 µM 2BP or 500 nM CNP plus
20 µM 2BP. Cells were then fixed and stained for NCAM1. Scale bar, 100 µm. (B5,B6) Quantification of the average and maximal axonal length showed that 2BP
abolished the CNP-induced axonal length. Control n = 87 cells; CNP n = 114; 2BP n = 132; 2BP plus CNP n = 122. (C1–C4) Control versus CNP-treated (500 nM)
E7 chick DRG growth cones (explants) (arrowheads) in the presence or absence of 20 µM palmostatin B and stained for α-tubulin (green) and F-actin (red). Scale
bar, 20 µm. (C5) Quantification of the average area of growth cones treated as in (C1–C4). Number of growth cones measured: 224 (control), 222 (CNP), 230
(PalmB) and 206 (PalmB CNP) in 3 independent experiments. (C6) Percentages of growth cones that were classified into three groups according to their area.
PalmB, palmostatin B. p < 0.0001 (∗∗∗), p < 0.001 (∗∗), p > 0.05 (ns), unpaired (A5,B5,B6,C5) or paired (C6) two-tailed t-test. Error bars represent SEM.
conformational shift that activates the enzyme to phosphorylate
serine or threonine residues of protein targets which are currently
unknown for the process of bifurcation (Figure 9A). In the
absence of one of these signaling components in mouse mutants
the bifurcation is completely disturbed. In vivo, genetic inhibition
of cGMP signaling does not generally impair the ability of sensory
axons to grow or to generate collaterals but specifically impairs
their ability to bifurcate (Dumoulin et al., 2018).
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FIGURE 9 | Illustration of the cGMP signaling cascade essential for bifurcation
of somatosensory axons in the spinal cord/hindbrain and of growth cone
shaping cell cultures. The growth cone enlargement induced by CNP in vitro is
considered as priming step for bifurcation which requires S-palmitoylation.
(A) In vivo CNP binds to its receptor Npr2 which generates cGMP from GTP.
cGMP in turn activates cGKIα that phosphorylates so far unknown targets
which are required for proper bifurcation and which might include growth cone
enlargement. (B) In vitro the same signaling cascade is activated by CNP that
mediates growth cone enlargement and increased in neurite outgrowth of
DRG neurons. Our results indicated that downstream of cGKI S-palmitoylation
might play a role in the remodeling of growth cones and in the increase of
neurite outgrowth.
To get further insights into the process of bifurcation
of somatosensory axons in this study we initially visualized
individual growth cones at the DREZ. A number of microscopic
images from sensory afferents at the DREZ strongly argue for
a splitting process of the growth cone to establish T-shaped
branches. Interstitial branching by an afferent that had already
turned into the longitudinal track of the spinal cord can be
considered as an implausible mechanism to generate cGMP-
induced T-branches (see also schematic of Figure 1A2 which
illustrates both options). Therefore, our data also suggest that
beyond CNP, Npr2 and cGKI additional components implicated
in the process of bifurcation still need to be identified in growth
cones.
Signaling pathways are often compartmentalized by
anchoring relevant components in larger complexes to ensure
spatiotemporal control of signaling. Compartmentation is
also essential to pick the correct target for phosphorylation.
For protein kinase A – the closest homolog of cGKI - a
number of AKAPs (for A kinase anchoring proteins) have been
characterized which immobilize PKA into scaffolds of signaling
complexes containing activators and substrates which are
phosphorylated by PKA (Torres-Quesada et al., 2017; Ercu and
Klussmann, 2018). cGKI is expressed as two isoforms, termed
α and β, that differ in their first ∼100 N-terminal residues.
These segments harbor a leucine zipper-like domain that directs
homodimerization and interactions with anchoring proteins
(Francis et al., 2010; Hofmann and Wegener, 2013). From these
two forms the α-form is expressed in DRG neurons (Schmidt
et al., 2002) which is translated from an alternatively produced
cGKI mRNA. Evidence for scaffolds involved in spatiotemporal
cGKI signaling is scarce – only a few have been defined for cGKIβ
(Francis et al., 2010; Hofmann and Wegener, 2013) and even less
for cGKIα (Yuasa et al., 2000; Wang et al., 2004). Our studies
showed that a substantial portion of cGKI is associated with
subcellular compartments in the C-domain of the growth cone
and suggests that anchoring mechanisms for cGKI might exist.
Axon bifurcation is a complex cell biological action involving
the coordination of several processes. In general it is thought
that intracellular signals provoking changes of the growth
cone morphology require the action of components of the
cytoskeleton and/or a tight control of protein trafficking. These
processes might function independently or might affect each
other (Tojima et al., 2011, 2014; Winkle et al., 2016). Both,
the pattern of localization of the cGKI in DRG growth cones
and blocking experiments by pharmacological reagents suggest
that CNP-induced signaling via Npr2 and cGKI might control
the regulation of intracellular protein trafficking by modulating
S-palmitoylation of proteins. A role for protein trafficking in the
process of axon bifurcation was observed for the peripheral but
not for the central branch of Rohon beard cells in Zebrafish.
Knockdowns of calsyntenin – a kinesin adaptor implicated in
intracellular trafficking – showed that it is required for both
interstitial branching and growth cone bifurcation. It regulates in
part the endosomal transport from the cell body to developing
axons and branch points by organizing microtubule polarity.
(Ponomareva et al., 2014; Lee et al., 2017). It is noteworthy that
calsyntenin knockdowns also influence processes which control
growth cone motility and growth cone volume of Rohon Beard
cells. In human patients disruption of the gene encoding the
zDHHC8 palmitoyltransferase contributes to schizophrenia and
in a mouse knockout of zDHHC8 a reduced branching of axon
collaterals was observed further indicating that S-palmitoylation
and trafficking might play a role in the formation of neuronal
circuits (Mukai et al., 2008, 2015).
Although bifurcation could not be induced in in vitro
cultures of embryonic DRGs we demonstrated that CNP is
critical for the shape of growth cones. Application of CNP
induced a growth cone remodeling resulting in an enlarged
area. This process might be considered as a priming step for
growth cone bifurcation. It required the presence of cGKI
indicating that the complete CNP/Npr2/cGKI signaling cascade
is implicated in the broadening of the growth cone area. This
CNP-mediated growth cone enlargement was blocked by broad-
spectrum S-palmitoylation blockers and was potentiated in the
presence of a thioesterase inhibitor suggesting that cGMP-
stimulated S-palmitoylation of proteins might be implicated in
growth cone shaping (Figure 9B). Long lasting effects of CNP
or cGMP were observed on the neurite length as also described
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by Zhao and Ma (2009) and on the attachment of DRG and
F11 cells to extracellular matrix components coated on culture
dishes. These findings are in line with the adhesion of vascular
smooth muscle cells induced by cGMP derivatives (Weinmeister
et al., 2008). cGKI was found to be localized primarily in the
C-domain of the growth cone in vesicular-like patterns and
was associated with intracellular structures such as the ER,
lysosomes, early endosomes and in the soma the Golgi apparatus
where the majority of zDHHCs palmitoyltransferases are located
(Fukata and Fukata, 2010; Chamberlain and Shipston, 2015).
Importantly, cGKI is localized close to intracellular membranes
that are enriched in palmitoyltransferases and might have a
certain proximity to proteins undergoing S-palmitoylation. In
comparison to the C-domain cGKI was only weakly expressed
in the P-domain which is characterized by actin filaments.
This faint localization of cGKI in the P-domain of the DRG
growth cone suggests that the influence of the cGKI on the
regulation of the F-actin cytoskeleton during the process of
T-branching might be limited. This subcellular localization of
cGKI in sensory growth cones is in line with observations on
different cell types where cGKI was detected in the perinuclear
region including colocalization with marker proteins of the ER
and Golgi apparatus (Ives et al., 1980; Cornwell et al., 1991;
Pryzwansky et al., 1995; Monks et al., 1998; Feil et al., 2002; Wang
et al., 2004; Casteel et al., 2008; Kato et al., 2015). Furthermore,
we observed a correlation between the location of cGKI and
the palmitoylome in extending growth cones. Consistently,
biochemical investigation using ABE chemistry demonstrated
that cGMP signaling induced by 8-pPCT-cGMP might modulate
S-palmitoylation of a restricted number of proteins in the DRG
derived cell line F11. Further studies on palmitoyltransferases
might substantiate this potential link between cGMP signaling
and palmitoylation.
Interestingly, two palmitoyltransferases zDHHC3 and 13 were
detected only in the palmitoylome fraction of 8-pCPT-cGMP-
treated F11 cells. This might suggest two possibilities in a context
of cGMP signaling: (1) either the enzymes get palmitoylated by
another one which might lead to their activation/inhibition or
they might traffic to other cellular compartments where they
will be able to palmitoylate another pool of proteins or (2) this
increase of palmitoylation might be taken as a possible increase
in their auto-palmitoylation state. As the auto-palmitoylation
state of palmitoyltransferases most likely correlates with their
activation state (Fukata et al., 2004; Jennings and Linder, 2012;
Chamberlain and Shipston, 2015), it might suggest that zDHHC3
and 13 get auto-palmitoylated under 8-pCPT-cGMP stimulation
which might reflect an increase in their activity toward specific
substrates. This also raises the question of how cGKI might
regulate S-palmitoylation. It might phosphorylate target proteins
which will get palmitoylated by specific palmitoyltransferases.
It might also activate indirectly (via downstream targets) but
also directly those enzymes. Interestingly, zDHHC5 has been
reported to undergo endocytosis after phosphorylation by the
Fyn kinase in hippocampal neurons (Brigidi et al., 2015) and
zDHHC3 activity has been reported to be controlled by Src kinase
in hippocampal neurons as well (Lievens et al., 2016). Therefore,
it is conceivable that cGKI might phosphorylate specific
palmitoyltransferases and modulate their activity or change their
subcellular localization. Four enzymes contain a cGKI putative
phosphorylation motif in their cytosolic domain (zDHHC1, 5,
8 and 23) and it will be interesting to know whether cGKI
phosphorylates these palmitoyltransferases. Phosphorylation of
specific proteins might also prevent palmitoylation. For example,
a negative influence of phosphorylation on S-palmitoylation was
found for phosphodiesterase 10A (Charych et al., 2010).
Currently, it remains a matter of discussion which of the
palmitoylated components identified by using the F11 cells
might be implicated in the regulation of sensory growth
cone remodeling – if at all. Only a few options will be
considered here. Palmitoylation might facilitate association
of candidates with intracellular transport vesicles and might
therefore guarantee efficient intracellular trafficking within
the axon or growth cone. Candidates might also include
proteins that regulate the organization of the microtubule
cytoskeleton or of cell adhesion proteins. For example the
Ras homolog family member A (RHOA) guanine nucleotide
exchange factor ARHGEF2 is tethered by the dynein motor light
chain DYNLT1 to the microtubule network (Meiri et al., 2012)
and interacts with a number of proteins that are implicated
in microtubule organization (Sandi et al., 2017). MAP4 has
been shown to regulate the movement of pigment granules
along microtubules to the cell center of Xenopus melanophores
(Semenova et al., 2014). Therefore, MAP4 attached vesicles
might promote the entry of new cargo into the expanding
growth cone or MAP4 might be transported via dense core
vesicles into the growth cone and after de-palmitoylation might
stabilize the microtubule network in the growth cone. Such a
mechanism has been demonstrated during axonal development
for palmitoylated MAP6 which is present in secretory vesicles
and the Golgi apparatus (Tortosa et al., 2017; Tortosa and
Hoogenraad, 2018). A role of cGKI in tubulin dynamics
which is linked to membrane trafficking to modulate growth
cone area or shape has been also described by in vitro
experiments (Xia et al., 2013). For the Ig superfamily adhesion
proteins belonging to the SynCAM family (SynCAM4 – 2-hit
protein candidate) an enlargement of sensory growth cones,
very similar to that observed here, was demonstrated if they
are offered as substrate in cell culture dishes (Frei et al.,
2014). Other potential candidates for growth cone enlargement
might be Mucolipin-1 (Mcoln1, also designated TRPML) or
Ndst1 (N-deacetylase/N-sulfotransferase). The latter controls
N-sulfation during heparin sulfate and heparin biosynthesis.
Absence of Ndst1 affects several signaling pathways such
as FGF, BMP, wnt and Hedgehog (Hh) which bind to
heparin sulfate and play a role in growth cone extension
(Pallerla et al., 2007; Ringvall and Kjellen, 2010). Interestingly,
Mcoln1 - a lysosomal cation channel - is known to play a
role in lysosomal exocytosis and vesicular transport to the
plasma membrane (Venkatachalam et al., 2015). Moreover, the
S-palmitoylation of its C-terminal tail leads to its association
with membranes and most likely to its presence at the cell
surface (Vergarajauregui and Puertollano, 2006) making this
candidate attractive in the context of Npr2-mediated growth cone
enlargement.
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Overall, on the basis of the growth cone reshaping by CNP
our results suggest that the CNP/Npr2/cGKI signaling pathway
might control axon bifurcation in part through palmitoylation
of selective proteins. In conclusion, our data on the localization
of cGKI in a vesicular-like pattern in the central domain of
the growth cone, on growth cone enlargement induced by CNP
that paralleled with palmitoylation further our understanding
of the process of bifurcation and establishes a potential link
between cGKI-mediated phosphorylation and the regulation of
palmitoylation.
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FIGURE S1 | CNP induced growth cone enlargement of cultured embryonic chick
DRG explants. (A1–A4) 1-h CNP stimulation increased the growth cone area of E7
chick DRGs cultured on a PDL/laminin1 substrate. DRG neurons were fixed and
stained for α-tubulin (green) and F-actin (red) (phalloidin). Control growth cones
appeared with an extended P-domain containing long filopodia (arrowheads)
whereas CNP-stimulated growth cones had a larger C-domain and shorter
filopodia (arrowheads). (B1) The average area of CNP-stimulated growth cones
increased 52% ± 6% (mean ± SEM) compared to control. (B2) The number of
small growth cones was drastically reduced (19% ± 3%, mean ± SEM) compared
to control (60% ± 2%, mean ± SEM) and the number of large growth cones was
significantly increased (46% ± 2%, mean ± SEM) compared to control
(12% ± 1%, mean ± SEM). (C1) The average length and maximum length of
filopodia at growth cones were reduced upon CNP stimulation of about
30% ± 1% and 38% ± 1% (mean ± SEM), respectively. (C2) The number of
filopodia per growth cone was unchanged by CNP application. Three independent
experiments. 170 growth cones (control) and 177 growth cones (CNP) were
assessed. p < 0.0001 (∗∗∗), p < 0.05 (∗), or p > 0.05 (ns), unpaired (B1,C1,C2)
and paired (B2) two-tailed t-test. Error bars represent SEM. Scale
bar, 20 µm.
FIGURE S2 | Analysis of the specificity of rabbit anti-cGKI antibodies. Explants
culture of embryonic DRGs on PDL/laminin1 were stained with rabbit anti-cGKI
(0.75 µg/ml, IgG fraction) or anti-α-tubulin. (A1–A3) DRG explant from wild type
cGKI mice. (B1–B3) DRG explant from cGKI-deficient mice. (C1–C3) Growth cone
from wild type mice. (D1–D3) Growth cone from cGKI-deficient mice. No signals
were detected for anti-cGKI in cGKI-deficient DRGs. Scale bar, 10 µm. Phall.,
phalloidin.
FIGURE S3 | Localization of cGKI in the central domain of chick DRG growth
cones cultivated on laminin1. (A1) α-tubulin, (A2) cGKI and (A3) α-tubulin and
F-actin (with phalloidin), (A4) α-tubulin and cGKI. (B1,B2) Intensity profiles of cGKI
and F-actin (phalloidin). Scale bar, 10 µm.
FIGURE S4 | Colocalization of cGKI with marker proteins of intracellular
compartments in DRG-derived F11 cells. (A1–A4) Colocalization between cGKI
and the ER marker PDI in F11 cells. (B1–B4) Colocalization between cGKI and the
lysosomal marker LAMP-1. (C1–C4) Colocalization between cGKI and the
cis-Golgi-marker GM-130. Enlargement of the squares in (A3–C3) are shown in
(A4–C4). (D) Quantification of co-localizations using Mander’s colocalization
coefficient (MCC). MCC values are given within the columns. tM1 value represents
MCC for cGKI versus marker and tM2 represents marker versus cGKI. For GM130
18 cells, for TGN130 18 cells, for γ-adaptin 14 cells, for PDI 16 cells, for Rab11 18
cells and for LAMP-1 10 cells were analyzed. Error bars represent SEM. Scale
bars, 20 µm.
FIGURE S5 | Biorthogonal labeling strategy of palmitoylated proteins in growth
cones of DRG neurons and in F11 cells. (A) DRG or F11 cells were grown
overnight in standard cell culture medium followed by a medium without FCS
supplemented with a palmitate analog containing an azide. The acyl synthase
couples the palmitate analog to CoA followed by incorporation into proteins
through zDHHCs palmitoyltransferases. Labeled proteins were detected by
biotin-PEG4-alkyne and the click reaction. Adapted from (Gao and Hannoush,
2014). (B) Titration of F11cells incubated overnight with different concentrations of
palmitic acid azide followed by the biorthogonal labeling procedure. 100 µM of
palmitic acid azide was found to be appropriate as also suggested by others (Gao
and Hannoush, 2014).
FIGURE S6 | RT-PCR analysis of the mRNA expression of 3-hit candidates in
E12.5 mouse DRGs. RT-PCR analysis of 3-hit candidates detected in the
membrane fraction of F11 cells in E12.5 DRGs (DRG) and in E17 whole mouse
embryo cDNA libraries (positive control, + ). Note that the third lane was loaded
with water as control (Ctrl). All candidates appeared to be expressed at the mRNA
level in mouse embryonic DRGs. Ctrl: water control. N/A, not attributed.
TABLE S1 | Antibodies and dilutions.
TABLE S2 | 2-hit and 3-hit palmitoylated protein candidates which were detected
only in the membrane samples of the F11 cells stimulated with a cGMP analogue
are listed. 3-hit candidates are in bold.
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